Jamie Platt - Jan 1, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role: Director
Signature: /s/ Maria Zannes, as attorney-in-fact for Jamie Platt
Stock symbol: BIAF
Transactions as of: Jan 1, 2024
Transactions value $: $18,749
Form type: 4
Date filed: 1/24/2024, 08:52 PM
Previous filing: Dec 8, 2023
Next filing: Jun 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIAF	Common Stock	Award	$18.7K	+12.7K		$1.48	12.7K	Jan 1, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant from the Issuer to Ms. Platt of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.

Content

Represents a grant from the Issuer to Ms. Platt of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.